ParkinsonFranceV1, Main, Exploration, bibRecord, 000245

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Identifieur interne : 000245 ( Main/Exploration ); précédent : 000244; suivant : 000246

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Auteurs : Olivier Rascol [France] ; Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Cheryl J. Fitzer-Attas [États-Unis] ; Yulia Sidi [Israël] ; Victor Abler [États-Unis] ; C Warren Olanow [États-Unis]

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2016.

RBID : pubmed:27431201

Abstract

The Attenuation of Disease progression with Azilect GIven Once-daily (ADAGIO) delayed-start study demonstrated a benefit of early-start treatment with rasagiline 1 mg/day versus delayed-start treatment in PD. This follow-up study aimed to assess whether these benefits persist and the clinical progression rate during long-term naturalistic treatment.

DOI: 10.1002/mds.26724
PubMed: 27431201

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term effects of rasagiline and the natural history of treated Parkinson's disease.</title>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="3"><nlm:affiliation>Departments of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC-1436, NS-Park/FCRIN Network and NeuroToul COEN Center of Excellence in Neurodegeneration, INSERM, University Hospital of Toulouse, and University of Toulouse 3, Toulouse, France. olivier.rascol@univ-tlse3.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Departments of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC-1436, NS-Park/FCRIN Network and NeuroToul COEN Center of Excellence in Neurodegeneration, INSERM, University Hospital of Toulouse, and University of Toulouse 3, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, Tampa, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stocchi, Fabrizio" sort="Stocchi, Fabrizio" uniqKey="Stocchi F" first="Fabrizio" last="Stocchi">Fabrizio Stocchi</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurology, Institute for Research and Medical Care IRCCS San Raffaele, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fitzer Attas, Cheryl J" sort="Fitzer Attas, Cheryl J" uniqKey="Fitzer Attas C" first="Cheryl J" last="Fitzer-Attas">Cheryl J. Fitzer-Attas</name>
<affiliation wicri:level="2"><nlm:affiliation>CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>CHDI Management/CHDI Foundation, Princeton, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sidi, Yulia" sort="Sidi, Yulia" uniqKey="Sidi Y" first="Yulia" last="Sidi">Yulia Sidi</name>
<affiliation wicri:level="1"><nlm:affiliation>Teva Pharmaceuticals, Petah Tikva, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Teva Pharmaceuticals, Petah Tikva</wicri:regionArea>
<wicri:noRegion>Petah Tikva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abler, Victor" sort="Abler, Victor" uniqKey="Abler V" first="Victor" last="Abler">Victor Abler</name>
<affiliation wicri:level="2"><nlm:affiliation>Teva Pharmaceuticals, Frazer, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Teva Pharmaceuticals, Frazer, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<affiliation wicri:level="2"><nlm:affiliation>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27431201</idno>
<idno type="pmid">27431201</idno>
<idno type="doi">10.1002/mds.26724</idno>
<idno type="wicri:Area/PubMed/Corpus">000078</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000078</idno>
<idno type="wicri:Area/PubMed/Curation">000078</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000078</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000078</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000078</idno>
<idno type="wicri:Area/Ncbi/Merge">001A81</idno>
<idno type="wicri:Area/Ncbi/Curation">001A81</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A81</idno>
<idno type="wicri:Area/Main/Merge">000247</idno>
<idno type="wicri:Area/Main/Curation">000245</idno>
<idno type="wicri:Area/Main/Exploration">000245</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term effects of rasagiline and the natural history of treated Parkinson's disease.</title>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="3"><nlm:affiliation>Departments of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC-1436, NS-Park/FCRIN Network and NeuroToul COEN Center of Excellence in Neurodegeneration, INSERM, University Hospital of Toulouse, and University of Toulouse 3, Toulouse, France. olivier.rascol@univ-tlse3.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Departments of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC-1436, NS-Park/FCRIN Network and NeuroToul COEN Center of Excellence in Neurodegeneration, INSERM, University Hospital of Toulouse, and University of Toulouse 3, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, Tampa, Florida, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stocchi, Fabrizio" sort="Stocchi, Fabrizio" uniqKey="Stocchi F" first="Fabrizio" last="Stocchi">Fabrizio Stocchi</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurology, Institute for Research and Medical Care IRCCS San Raffaele, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fitzer Attas, Cheryl J" sort="Fitzer Attas, Cheryl J" uniqKey="Fitzer Attas C" first="Cheryl J" last="Fitzer-Attas">Cheryl J. Fitzer-Attas</name>
<affiliation wicri:level="2"><nlm:affiliation>CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>CHDI Management/CHDI Foundation, Princeton, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sidi, Yulia" sort="Sidi, Yulia" uniqKey="Sidi Y" first="Yulia" last="Sidi">Yulia Sidi</name>
<affiliation wicri:level="1"><nlm:affiliation>Teva Pharmaceuticals, Petah Tikva, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Teva Pharmaceuticals, Petah Tikva</wicri:regionArea>
<wicri:noRegion>Petah Tikva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abler, Victor" sort="Abler, Victor" uniqKey="Abler V" first="Victor" last="Abler">Victor Abler</name>
<affiliation wicri:level="2"><nlm:affiliation>Teva Pharmaceuticals, Frazer, Pennsylvania, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Teva Pharmaceuticals, Frazer, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<affiliation wicri:level="2"><nlm:affiliation>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Attenuation of Disease progression with Azilect GIven Once-daily (ADAGIO) delayed-start study demonstrated a benefit of early-start treatment with rasagiline 1 mg/day versus delayed-start treatment in PD. This follow-up study aimed to assess whether these benefits persist and the clinical progression rate during long-term naturalistic treatment.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
<li>Israël</li>
<li>Italie</li>
<li>États-Unis</li>
</country>
<region><li>Floride</li>
<li>Latium</li>
<li>Midi-Pyrénées</li>
<li>New Jersey</li>
<li>Occitanie (région administrative)</li>
<li>Pennsylvanie</li>
<li>État de New York</li>
</region>
<settlement><li>Rome</li>
<li>Toulouse</li>
</settlement>
</list>
<tree><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
</region>
</country>
<country name="États-Unis"><region name="Floride"><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A" last="Hauser">Robert A. Hauser</name>
</region>
<name sortKey="Abler, Victor" sort="Abler, Victor" uniqKey="Abler V" first="Victor" last="Abler">Victor Abler</name>
<name sortKey="Fitzer Attas, Cheryl J" sort="Fitzer Attas, Cheryl J" uniqKey="Fitzer Attas C" first="Cheryl J" last="Fitzer-Attas">Cheryl J. Fitzer-Attas</name>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</country>
<country name="Italie"><region name="Latium"><name sortKey="Stocchi, Fabrizio" sort="Stocchi, Fabrizio" uniqKey="Stocchi F" first="Fabrizio" last="Stocchi">Fabrizio Stocchi</name>
</region>
</country>
<country name="Israël"><noRegion><name sortKey="Sidi, Yulia" sort="Sidi, Yulia" uniqKey="Sidi Y" first="Yulia" last="Sidi">Yulia Sidi</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000245 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000245 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27431201
   |texte=   Long-term effects of rasagiline and the natural history of treated Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27431201" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

La maladie de Parkinson en France (serveur d'exploration)

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Long-term effects of rasagiline and the natural history of treated Parkinson's disease.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.